{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:39:44Z","timestamp":1773283184523,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ijantimicag.2012.10.014","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T20:14:41Z","timestamp":1357676081000},"page":"224-228","source":"Crossref","is-referenced-by-count":29,"title":["Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002\u20132010"],"prefix":"10.1016","volume":"41","author":[{"given":"Stephen P.","family":"Hawser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Badal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel K.","family":"Bouchillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daryl J.","family":"Hoban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas J.","family":"Biedenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Cant\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/501572","article-title":"The impact of surgical site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs","volume":"20","author":"Kirkland","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0010","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/501571","article-title":"The price of a surgical site infection: more than just excess length of stay","volume":"20","author":"Wong","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0020","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/AAC.05913-11","article-title":"Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae","volume":"56","author":"Collins","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1345\/aph.1Q473","article-title":"Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extended-spectrum \u03b2-lactamase producing Gram-negative bacteria","volume":"46","author":"Fong","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0030","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/AAC.05650-11","article-title":"Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States","volume":"56","author":"Park","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0035","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jac\/dkq108","article-title":"Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection","volume":"65","author":"Hirsch","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/dkl483","article-title":"CTX-M: changing the face of ESBLs in Europe","volume":"59","author":"Livermore","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ijantimicag.2006.11.020","article-title":"Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory","volume":"29","author":"Woodford","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0050","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/jac\/dkn396","article-title":"Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom","volume":"62","author":"Woodford","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0055","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1179\/joc.2011.23.5.266","article-title":"Trending eight years of in vitro activity of ertapenem and comparators against Escherichia coli from intra-abdominal infections in North America\u2014SMART 2002\u20132009","volume":"23","author":"Hawser","year":"2011","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0060","first-page":"218","article-title":"The impact of carbapenemases on antimicrobial development and therapy","volume":"3","author":"Livermore","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0065","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1086\/594129","article-title":"Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure","volume":"29","author":"Srinivasan","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0070","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/CMR.18.2.306-325.2005","article-title":"Metallo-\u03b2-lactamases: the quiet before the storm?","volume":"18","author":"Walsh","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jac\/dki412","article-title":"Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum \u03b2-lactamases","volume":"57","author":"Woodford","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0080","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 9th ed. Document M7-A9. Wayne, PA: CLSI; 2012."},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0085","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. Document M100-S22. Wayne, PA: CLSI; 2012."},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0090","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/sur.2009.057","article-title":"Epidemiologic trends, occurrence of extended-spectrum \u03b2-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002\u20132007 from the SMART study","volume":"11","author":"Hawser","year":"2010","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0095","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/AAC.00265-10","volume":"54","author":"Hawser","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0100","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/AAC.01808-09","article-title":"Susceptibility of Gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007\u20132008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"54","author":"Hoban","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0105","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijantimicag.2010.07.002","volume":"36","author":"Hsueh","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0110","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010."},{"key":"10.1016\/j.ijantimicag.2012.10.014_bib0115","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1001\/jama.2008.896","article-title":"Carbapenem-resistant Enterobacteriaceae: a potential threat","volume":"300","author":"Schwaber","year":"2008","journal-title":"JAMA"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912004256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912004256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T17:23:19Z","timestamp":1539969799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857912004256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0924857912004256"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.10.014","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}